Bronchial adenoma: an unusual cause of recurrent pneumonia in childhood.

F. Morini,S. Quattrucci,D. Cozzi,G. Tancredi,Anna Maria Cicconi,R. Guidi,F. Midulla

DOI: https://doi.org/10.1016/S0003-4975(03)01047-6

2003-12-01

Abstract:

What problem does this paper attempt to address?

Immune Responses to Broad-Spectrum Antibiotic Treatment and Fecal Microbiota Transplantation in Mice

Ira Ekmekciu,Eliane von Klitzing,Ulrike Fiebiger,Ulrike Escher,Christian Neumann,Petra Bacher,Alexander Scheffold,Anja A Kühl,Stefan Bereswill,Markus M Heimesaat

DOI: https://doi.org/10.3389/fimmu.2017.00397

2017-04-19

Abstract:Compelling evidence demonstrates the pivotal role of the commensal intestinal microbiota in host physiology and the detrimental effects of its perturbations following antibiotic treatment. Aim of this study was to investigate the impact of antibiotics induced depletion and subsequent restoration of the intestinal microbiota composition on the murine mucosal and systemic immunity. To address this, conventional C57BL/6j mice were subjected to broad-spectrum antibiotic treatment for 8 weeks. Restoration of the intestinal microbiota by peroral fecal microbiota transplantation (FMT) led to reestablishment of small intestinal CD4+, CD8+, and B220+ as well as of colonic CD4+ cell numbers as early as 7 days post-FMT. However, at d28 following FMT, colonic CD4+ and B220+ cell numbers were comparable to those in secondary abiotic (ABx) mice. Remarkably, CD8+ cell numbers were reduced in the colon upon antibiotic treatment, and FMT was not sufficient to restore this immune cell subset. Furthermore, absence of gut microbial stimuli resulted in decreased percentages of memory/effector T cells, regulatory T cells, and activated dendritic cells in the small intestine, colon, mesenteric lymph nodes (MLN), and spleen. Concurrent antibiotic treatment caused decreased cytokine production (IFN-γ, IL-17, IL-22, and IL-10) of CD4+ cells in respective compartments. These effects were, however, completely restored upon FMT. In summary, broad-spectrum antibiotic treatment resulted in profound local (i.e., small and large intestinal), peripheral (i.e., MLN), and systemic (i.e., splenic) changes in the immune cell repertoire that could, at least in part, be restored upon FMT. Further studies need to unravel the distinct molecular mechanisms underlying microbiota-driven changes in immune homeostasis subsequently providing novel therapeutic or even preventive approaches in human immunopathologies.
Enterocloster clostridioformis induces host intestinal epithelial responses that protect against Salmonella infection

Benjamin S. Beresford-Jones,Satoshi Suyama,Simon Clare,Amelia Soderholm,Wangmingyu Xia,Puspendu Sardar,Katherine Harcourt,Trevor D. Lawley,Virginia A. Pedicord,Beresford-Jones,B. S.,Suyama,S.,Clare,S. A.,Soderholm,A. T.,Xia,W.,Sardar,P.,Harcourt,K.,Lawley,T. D.,Pedicord,V. A.

DOI: https://doi.org/10.1101/2023.07.20.549886

2023-07-21

bioRxiv

Abstract:Promoting resistance to enteric pathogen infection is a core function of the gut microbiota. However, many of the host-commensal interactions that likely mediate this protection remain uncharacterised. By screening gnotobiotic mice monocolonised with a range of mouse-derived commensal bacteria we have identified Enterocloster clostridioformis as a protective species against Salmonella Typhimurium infection. Unlike the colonisation resistance induced by some commensal bacteria, E. clostridioformis selectively induces a previously uncharacterised microbe adaptation response at the level of the caecal intestinal epithelium and the underlying mucosal immune system to mediate host-dependent resistance to infection. Triggering this pathway may therefore constitute a novel strategy to enhance protective responses against enteric infections.
Citrobacter rodentium–host–microbiota interactions: immunity, bioenergetics and metabolism

Caroline Mullineaux-Sanders,Julia Sanchez-Garrido,Eve G. D. Hopkins,Avinash R. Shenoy,Rachael Barry,Gad Frankel

DOI: https://doi.org/10.1038/s41579-019-0252-z

IF: 88.1

2019-09-20

Nature Reviews Microbiology

Abstract:Citrobacter rodentium is an extracellular enteric mouse-specific pathogen used to model infections with human pathogenic Escherichia coli and inflammatory bowel disease. C. rodentium injects type III secretion system effectors into intestinal epithelial cells (IECs) to target inflammatory, metabolic and cell survival pathways and establish infection. While the host responds to infection by activating innate and adaptive immune signalling, required for clearance, the IECs respond by rapidly shifting bioenergetics to aerobic glycolysis, which leads to oxygenation of the epithelium, an instant expansion of mucosal-associated commensal Enterobacteriaceae and a decline of obligate anaerobes. Moreover, infected IECs reprogramme intracellular metabolic pathways, characterized by simultaneous activation of cholesterol biogenesis, import and efflux, leading to increased serum and faecal cholesterol levels. In this Review we summarize recent advances highlighting the intimate relationship between C. rodentium pathogenesis, metabolism and the gut microbiota.

microbiology
Genome-guided design of a defined mouse microbiota that confers colonization resistance against Salmonella enterica serovar Typhimurium

Sandrine Brugiroux,Markus Beutler,Carina Pfann,Debora Garzetti,Hans-Joachim Ruscheweyh,Diana Ring,Manuel Diehl,Simone Herp,Yvonne Lötscher,Saib Hussain,Boyke Bunk,Rüdiger Pukall,Daniel H. Huson,Philipp C. Münch,Alice C. McHardy,Kathy D. McCoy,Andrew J. Macpherson,Alexander Loy,Thomas Clavel,David Berry,Bärbel Stecher

DOI: https://doi.org/10.1038/nmicrobiol.2016.215

IF: 28.3

2016-11-21

Nature Microbiology

Abstract:Protection against enteric infections, also termed colonization resistance, results from mutualistic interactions of the host and its indigenous microbes. The gut microbiota of humans and mice is highly diverse and it is therefore challenging to assign specific properties to its individual members. Here, we have used a collection of murine bacterial strains and a modular design approach to create a minimal bacterial community that, once established in germ-free mice, provided colonization resistance against the human enteric pathogen Salmonella enterica serovar Typhimurium (S. Tm). Initially, a community of 12 strains, termed Oligo-Mouse-Microbiota (Oligo-MM12), representing members of the major bacterial phyla in the murine gut, was selected. This community was stable over consecutive mouse generations and provided colonization resistance against S. Tm infection, albeit not to the degree of a conventional complex microbiota. Comparative (meta)genome analyses identified functions represented in a conventional microbiome but absent from the Oligo-MM12. By genome-informed design, we created an improved version of the Oligo-MM community harbouring three facultative anaerobic bacteria from the mouse intestinal bacterial collection (miBC) that provided conventional-like colonization resistance. In conclusion, we have established a highly versatile experimental system that showed efficacy in an enteric infection model. Thus, in combination with exhaustive bacterial strain collections and systems-based approaches, genome-guided design can be used to generate insights into microbe–microbe and microbe–host interactions for the investigation of ecological and disease-relevant mechanisms in the intestine.

microbiology
Intestinal Microbiota as a Host Defense Mechanism to Infectious Threats

Simona Iacob,Diana Gabriela Iacob,Luminita Monica Luminos

DOI: https://doi.org/10.3389/fmicb.2018.03328

2019-01-23

Abstract:The intestinal microbiota is a complex microbial community, with diverse and stable populations hosted by the gastrointestinal tract since birth. This ecosystem holds multiple anti-infectious, anti-inflammatory, and immune modulating roles decisive for intestinal homeostasis. Among these, colonization resistance refers to the dynamic antagonistic interactions between commensals and pathogenic flora. Hence, gut bacteria compete for the same intestinal niches and substrates, while also releasing antimicrobial substances such as bacteriocines and changing the environmental conditions. Short chain fatty acids (SCFAs) generated in anaerobic conditions prompt epigenetic regulatory mechanisms that favor a tolerogenic immune response. In addition, the commensal flora is involved in the synthesis of bactericidal products, namely secondary biliary acids or antimicrobial peptides (AMPs) such as cathellicidin-LL37, an immunomodulatory, antimicrobial, and wound healing peptide. Gut microbiota is protected through symbiotic relations with the hosting organism and by quorum sensing, a specific cell-to-cell communication system. Any alterations of these relationships favor the uncontrollable multiplication of the resident pathobionts or external entero-pathogens, prompting systemic translocations, inflammatory reactions, or exacerbations of bacterial virulence mechanisms (T6SS, T3SS) and ultimately lead to gastrointestinal or systemic infections. The article describes the metabolic and immunological mechanisms through which the intestinal microbiota is both an ally of the organism against enteric pathogens and an enemy that favors the development of infections.
Klebsiella Michiganensis Transmission Enhances Resistance to Enterobacteriaceae Gut Invasion by Nutrition Competition

Rita A. Oliveira,Katharine M. Ng,Margarida B. Correia,Vitor Cabral,Handuo Shi,Justin L. Sonnenburg,Kerwyn Casey Huang,Karina B. Xavier

DOI: https://doi.org/10.1038/s41564-019-0658-4

IF: 28.3

2020-01-01

Nature Microbiology

Abstract:Co-housing mice is shown to induce resistance against enterobacterial infection after antibiotic treatment through the ability to retain or share Klebsiella michiganensis, which is necessary and sufficient to prevent infection through competition for nutrients. Intestinal microbiotas contain beneficial microorganisms that protect against pathogen colonization; treatment with antibiotics disrupts the microbiota and compromises colonization resistance. Here, we determine the impact of exchanging microorganisms between hosts on resilience to the colonization of invaders after antibiotic-induced dysbiosis. We assess the functional consequences of dysbiosis using a mouse model of colonization resistance against Escherichia coli. Antibiotics caused stochastic loss of members of the microbiota, but the microbiotas of co-housed mice remained more similar to each other compared with the microbiotas among singly housed animals. Strikingly, co-housed mice maintained colonization resistance after treatment with antibiotics, whereas most singly housed mice were susceptible to E. coli. The ability to retain or share the commensal Klebsiella michiganensis, a member of the Enterobacteriaceae family, was sufficient for colonization resistance after treatment with antibiotics. K. michiganensis generally outcompeted E. coli in vitro, but in vivo administration of galactitol-a nutrient that supports the growth of only E. coli-to bi-colonized gnotobiotic mice abolished the colonization-resistance capacity of K. michiganensis against E. coli, supporting the idea that nutrient competition is the primary interaction mechanism. K. michiganensis also hampered colonization of the pathogen Salmonella, prolonging host survival. Our results address functional consequences of the stochastic effects of microbiota perturbations, whereby microbial transmission through host interactions can facilitate reacquisition of beneficial commensals, minimizing the negative impact of antibiotics.
Commensal microbiome and gastrointestinal mucosal immunity: Harmony and conflict with our closest neighbor

Kexin Tian,Dehong Jing,Junzhe Lan,Mingming Lv,Tingting Wang

DOI: https://doi.org/10.1002/iid3.1316

2024-07-20

Immunity Inflammation and Disease

Abstract:The intestinal mucosal immune system, intricately linked with commensal microorganisms, orchestrates immune responses to pathogens, and the symbiotic flora plays a crucial role in maintaining a dynamic balance of mucosal immunity. This paper provides a comprehensive overview of the interplay between the two, serving as a valuable resource for future research on their relationships and potential implications for intestinal disorders. Background The gastrointestinal tract contains a wide range of microorganisms that have evolved alongside the immune system of the host. The intestinal mucosa maintains balance within the intestines by utilizing the mucosal immune system, which is controlled by the complex gut mucosal immune network. Objective This review aims to comprehensively introduce current knowledge of the gut mucosal immune system, focusing on its interaction with commensal bacteria. Results The gut mucosal immune network includes gut‐associated lymphoid tissue, mucosal immune cells, cytokines, and chemokines. The connection between microbiota and the immune system occurs through the engagement of bacterial components with pattern recognition receptors found in the intestinal epithelium and antigen‐presenting cells. This interaction leads to the activation of both innate and adaptive immune responses. The interaction between the microbial community and the host is vital for maintaining the balance and health of the host's mucosal system. Conclusion The gut mucosal immune network maintains a delicate equilibrium between active immunity, which defends against infections and damaging non‐self antigens, and immunological tolerance, which allows for the presence of commensal microbiota and dietary antigens. This balance is crucial for the maintenance of intestinal health and homeostasis. Disturbance of gut homeostasis leads to enduring or severe gastrointestinal ailments, such as colorectal cancer and inflammatory bowel disease. Utilizing these factors can aid in the development of cutting‐edge mucosal vaccines that have the ability to elicit strong protective immune responses at the primary sites of pathogen invasion.

immunology
Host innate and adaptive immunity shapes the gut microbiota biogeography

Min Gu,Derrick R. Samuelson,Nicholas M. Rua,Tysheena P. Charles,Christopher M. Taylor,Meng Luo,Robert W. Siggins,Judd E. Shellito,David A. Welsh

DOI: https://doi.org/10.1111/1348-0421.12963

2022-01-24

Microbiology and Immunology

Abstract:The gut microbiota has a fundamental role in the development and the maturation of the host immune system. Both innate and adaptive immune cells have critical functions in microbial pathogen containment and clearance, but the regulation of the commensal microbiome ecosystem in the gastrointestinal tract by these major immune cell populations is incompletely defined. The role of specific innate and adaptive immune cell in the regulation of the microbiota in the intestinal tract biogeographically was investigated. Dendritic cells, macrophages, CD4+ T-cells, CD8+ T-cells, and B-cells were depleted using monoclonal antibodies and clodronate liposomes, and the microbial communities were determined by 16S rRNA gene sequencing. With specific immune cell depletion, distinct microbiota changes were observed. In general, immune cell depleted mice had higher microbiota richness and evenness at all gut anatomical sites. At each gut segment, samples from immune cell-depleted animals clustered away from the isotype/liposome control mice. This was especially dramatic for the small intestinal microbiota. Specifically, Enterobacteriaceae, Bacteroides acidifaciens, and Mucispirillum schaedleri were highly enriched in the mucosa and lumen of the small intestine in immune cell-deficient animals. Further, the mucosal microbiota had higher microbiota evenness compared with luminal microbiota at all gut segments, and the UniFrac distance between B cell depleted and isotype control mice was the largest in the duodenum followed by the ileum and colon. Taken together, the data suggest that innate and adaptive immune cells specifically contribute to the regulation of the gut microbiota's biogeographical distribution along the gastrointestinal tract, and microbiota in the duodenum mucosa are more responsive to host immune changes compared with other anatomical sites.

immunology,microbiology
Host-recognition of pathogens and commensals in the mammalian intestine

Oriana Rossi,Peter van Baarlen,Jerry M Wells

DOI: https://doi.org/10.1007/82_2011_191

Abstract:To peacefully coexist with the microbial inhabitants of the intestine, mammals have evolved elaborate and interconnected regulatory mechanisms to maintain immune homeostasis in the face of potential infection and tissue damage by pathogenic microorganisms. Physical barriers, antimicrobial factors and secretory antibodies act in concert to keep microbes at a distance from the epithelium and initiate repair mechanisms in the event of damage. Commensal bacteria are not ignored but dynamically controlled via many complex overlapping and intertwined mechanisms involving intestinal epithelial cells (IECs) and signals from the microbiota. Polarized IECs play a decisive role in homeostasis by regulating the expression and activity of the pattern-recognition receptors (PRRs), in different compartments of the intestine. The differential signaling and expression of receptors on apical and basal membranes of the epithelium also plays its part in distinguishing commensals from harmful invaders. In steady state conditions macrophages and dendritic cells (DCs) in the lamina propria (LP) are conditioned by environmental factors to induce immune tolerance. The distinction between pathogen and non-pathogen is linked to the ability of pathogens to invade and cause damage to the host cells and tissues. This induces local inflammatory responses and the attraction of capillary leukocytes by chemokines released from colonized and invaded epithelial cells. This bypasses the tolerogenic mechanisms controlling the responses of resident DCs and macrophages leading to pathogen killing and adaptive immune responses. Research on this topic has important implications for the development of novel therapeutic approaches to treat or prevent inflammatory bowel disease (IBD), inflammation-related cancer and other gut-related diseases and disorders.
Selective influence of host microbiota on cAMP-mediated ion transport in mouse colon

K W Lomasney,A Houston,F Shanahan,T G Dinan,J F Cryan,N P Hyland

DOI: https://doi.org/10.1111/nmo.12328

Abstract:More microbes are resident in the distal colon than any other part of the body, and this microbiota has the capacity to influence enteric nerve development, excitability, and gastrointestinal function. Germ-free (GF) mice are a valuable tool in interrogating the communication between microbiota and host. Despite the intimate relationship which exists between the microbiota and the colonic mucosa-submucosa, there is a paucity of studies examining the influence of the microbiota on secretogogue-evoked responses. To this end, we investigated both epithelial and neural-evoked ion transport, and the response elicited by two commensal organisms, in colonic mucosa-submucosa preparations from GF mice in Ussing chambers. Baseline electrical parameters, short-circuit current and transepithelial resistance, were comparable between tissues from GF and conventional animals. Noteworthy, however, was a hyper-responsiveness of GF colon to forskolin stimulation. In contrast, the absence of the microbiota did not influence the tissue response to bethanechol. Moreover, responses to the sodium-channel activator, veratridine, and the TRPV1 receptor agonist, capsaicin were preserved in GF mice relative to conventional tissues. Similarly, the short-circuit current response to two well-characterized commensal organisms occurred independent of an interaction with the host microbiota. This is the first comprehensive characterization of secretomotor responses in GF colon.
Select mucosa-associated intestinal commensal bacteria promote gut barrier repair by inducing IL-1b production

Wan-Jung Wu,Myunghoo Kim,Lin-Chun Chang,Adrien Assie,Fatima B Saldana-Morales,Daniel Fernando Zegarra Ruiz,Kendra Norwood,Buck Samuel,Gretchen E. Diehl

DOI: https://doi.org/10.4049/jimmunol.208.supp.171.01

2022-05-01

The Journal of Immunology

Abstract:Abstract Microbiota interactions with host tissue support proper intestinal functions. In diseases such as inflammatory bowel disease, microbial shift along with epithelial dysfunctions are found. Understanding how intestinal epithelial functions are regulated by distinct commensal bacteria is key to improving outcomes in such diseases. Here, we identified a mouse commensal E. coli isolate, GDAR2-2, that promotes intestinal barrier repair in mouse colitis models including Citrobacter rodentium infection and dextran sulfate sodium-induced colitis. In mice, protection after GDAR2-2 colonization depends on CX3CR1+ mononuclear phagocytes (MNPs), which induce expansion of IL-22-secreting type 3 innate lymphoid cells. We detect upregulation of markers of transit amplifying cells, proliferation of which is downstream of IL-22 signaling. Protection is lost if IL-22 is blocked, indicating IL-22 driven epithelial regeneration is downstream of GDAR2-2 colonization. By co-culturing bone marrow derived macrophages with live GDAR2-2, we found GDAR2-2 promotes IL-1b production and the in vivo protection was lost after blockade of IL-1b. We further identified a subset of human commensal E. coli isolates that similarly induce CX3CR1+ MNP expansion and IL-1b mediated protection from C. rodentium infection in mice. This study reveals an unexpected role for IL-1b that promotes intestinal barrier repair and is induced by select commensal bacteria. Supported by NIH (AI125264, P30DK056338)

immunology
Modulation of Mucosal Immune Response, Tolerance, and Proliferation in Mice Colonized by the Mucin-Degrader Akkermansia muciniphila

Muriel Derrien,Peter Van Baarlen,Guido Hooiveld,Elisabeth Norin,Michael Müller,Willem M. de Vos

DOI: https://doi.org/10.3389/fmicb.2011.00166

IF: 5.2

2011-01-01

Frontiers in Microbiology

Abstract:Epithelial cells of the mammalian intestine are covered with a mucus layer that prevents direct contact with intestinal microbes but also constitutes a substrate for mucus-degrading bacteria. To study the effect of mucus degradation on the host response, germ-free mice were colonized with Akkermansia muciniphila. This anaerobic bacterium belonging to the Verrucomicrobia is specialized in the degradation of mucin, the glycoprotein present in mucus, and found in high numbers in the intestinal tract of human and other mammalian species. Efficient colonization of A. muciniphila was observed with highest numbers in the cecum, where most mucin is produced. In contrast, following colonization by Lactobacillus plantarum, a facultative anaerobe belonging to the Firmicutes that ferments carbohydrates, similar cell-numbers were found at all intestinal sites. Whereas A. muciniphila was located closely associated with the intestinal cells, L. plantarum was exclusively found in the lumen. The global transcriptional host response was determined in intestinal biopsies and revealed a consistent, site-specific, and unique modulation of about 750 genes in mice colonized by A. muciniphila and over 1500 genes after colonization by L. plantarum. Pathway reconstructions showed that colonization by A. muciniphila altered mucosal gene expression profiles toward increased expression of genes involved in immune responses and cell fate determination, while colonization by L. plantarum led to up-regulation of lipid metabolism. These indicate that the colonizers induce host responses that are specific per intestinal location. In conclusion, we propose that A. muciniphila modulates pathways involved in establishing homeostasis for basal metabolism and immune tolerance toward commensal microbiota.

microbiology
Microbiota-mediated colonization resistance against intestinal pathogens

Charlie G. Buffie,Eric G. Pamer

DOI: https://doi.org/10.1038/nri3535

IF: 108.555

2013-10-07

Nature Reviews Immunology

Abstract:Key PointsAntibiotic treatment disrupts the native intestinal microbiota and favours infection with and the proliferation of antibiotic-resistant intestinal pathogens. Clinically important antibiotic-resistant pathogens include vancomycin-resistant Enterococcus spp., various Enterobacteriaceae and Clostridium difficile.The intestinal microbiota influences the development, the maintenance and the function of the innate and adaptive immune systems. Host immune function is decreased in the intestines following antibiotic therapy, and antibiotic-treated hosts are susceptible to intestinal infection.Microbiota-derived bacterial populations and products that enhance immune defence against intestinal pathogens are being identified. However, the precise bacterial sources of many immunomodulatory molecules remain unclear and, conversely, the molecular mechanisms by which most probiotics restore immunity have yet to be elucidated.In addition to indirectly enhancing colonization resistance by stimulating host immune defences, bacterial populations can directly suppress intestinal pathogens by competitive exclusion and by antimicrobial activities. The commensal populations that are responsible for direct antagonism of pathogens and indirect, immune-mediated colonization resistance may be closely related and difficult to distinguish.Microbiota-derived bacterial populations and products, a subset of which enhance immune defence, can also promote intestinal inflammation, whereas other microbiota components restrain effector responses and promote tolerance.Manipulation of the intestinal microbiota to prevent and to treat some intestinal infections, such as C. difficile, shows promise in human patients and animal models of infection. However, the specific contributions of the individual bacterial populations that constitute the consortia transferred in such studies remain mostly undefined.

immunology
Gut complement induced by the microbiota combats pathogens and spares commensals

Meng Wu,Wen Zheng,Xinyang Song,Bin Bao,Yuanyou Wang,Deepshika Ramanan,Daping Yang,Rui Liu,John C. Macbeth,Elyza A. Do,Warrison A. Andrade,Tiandi Yang,Hyoung-Soo Cho,Francesca S. Gazzaniga,Marit Ilves,Daniela Coronado,Charlotte Thompson,Saiyu Hang,Isaac M. Chiu,Jeffrey R. Moffitt,Ansel Hsiao,John J. Mekalanos,Christophe Benoist,Dennis L. Kasper

DOI: https://doi.org/10.1016/j.cell.2023.12.036

2024-01-28

Cell Journal

Abstract:Summary Canonically, the complement system is known for its rapid response to remove microbes in the bloodstream. However, relatively little is known about a functioning complement system on intestinal mucosal surfaces. Herein, we report the local synthesis of complement component 3 (C3) in the gut, primarily by stromal cells. C3 is expressed upon commensal colonization and is regulated by the composition of the microbiota in healthy humans and mice, leading to an individual host's specific luminal C3 levels. The absence of membrane attack complex (MAC) components in the gut ensures that C3 deposition does not result in the lysis of commensals. Pathogen infection triggers the immune system to recruit neutrophils to the infection site for pathogen clearance. Basal C3 levels directly correlate with protection against enteric infection. Our study reveals the gut complement system as an innate immune mechanism acting as a vigilant sentinel that combats pathogens and spares commensals. Graphical abstract Download : Download high-res image (248KB) Download : Download full-size image

cell biology
Sequestration of gut pathobionts in intraluminal casts, a mechanism to avoid dysregulated T cell activation by pathobionts

Martina Sassone-Corsi,Shalhevet Azriel,Ariel Simon,Deepshika Ramanan,Adriana Ortiz-Lopez,Felicia Chen,Nissan Yissachar,Diane Mathis,Christophe Benoist

DOI: https://doi.org/10.1073/pnas.2209624119

2022-10-11

Abstract:T cells that express the transcription factor RORγ, regulatory (Treg), or conventional (Th17) are strongly influenced by intestinal symbionts. In a genetic approach to identify mechanisms underlying this influence, we performed a screen for microbial genes implicated, in germfree mice monocolonized with Escherichia coli Nissle. The loss of capsule-synthesis genes impaired clonal expansion and differentiation of intestinal RORγ+ T cells. Mechanistic exploration revealed that the capsule-less mutants remained able to induce species-specific immunoglobulin A (IgA) and were highly IgA-coated. They could still trigger myeloid cells, and more effectively damaged epithelial cells in vitro. Unlike wild-type microbes, capsule-less mutants were mostly engulfed in intraluminal casts, large agglomerates composed of myeloid cells extravasated into the gut lumen. We speculate that sequestration in luminal casts of potentially harmful microbes, favored by IgA binding, reduces the immune system's actual exposure, preserving host-microbe equilibrium. The variable immunostimulation by microbes that has been charted in recent years may not solely be conditioned by triggering molecules or metabolites but also by physical limits to immune system exposure.
[Experimental study of influenza-diphtheria-whooping cough vaccine. (Part I) Immunological reaction to influenza antigen].

N. N. Sokolova,N. I. Apanashchenko,V. Zhdanov

Abstract:
Human gut commensal modulates the host lipidome and delivers anti-inflammatory outer membrane vesicles to suppress colitis in an -deficient mouse model

Ethan A. Older,Mary K. Mitchell,Andrew Campbell,Xiaoying Lian,Michael Madden,Yuzhen Wang,Lauren E. van de Wal,Thelma Zaw,Brandon N. VanderVeen,Rodney Tatum,E. Angela Murphy,Yan-Hua Chen,Daping Fan,Melissa Ellermann,Jie Li

DOI: https://doi.org/10.1101/2024.10.23.619966

2024-10-24

Abstract:Correlative studies have linked human gut microbes to specific health conditions. is one such microbial genus negatively linked to inflammatory bowel disease (IBD). However, the protective role of in IBD has not been studied and the underlying molecular mechanisms also remain unknown. In this study, colonization of -deficient mice with DSM 27924 delays the development of colitis. Colonization with does not significantly alter the gut microbiome composition during colitis development, but instead shifts the host plasma lipidome, increasing phosphatidic acids while decreasing triglycerides. Outer membrane vesicles (OMVs) derived from are also detected in the plasma of colonized mice, which carry metabolites with immunomodulatory potential into the host circulatory system. We further demonstrate that fractions of OMVs suppress LPS-induced , , and expression in murine macrophages. We detect immunomodulatory sulfonolipids (SoLs) in the active fraction, which are also increased in the blood of -colonized mice; and we identify other putative bioactive lipids in the OMVs. Thus, OMVs represent a potential mechanism for -mediated delay of colitis progression in -deficient mice through the delivery of immunomodulatory lipids, including SoLs, and modulation of the host plasma lipidome.

Biochemistry
A conserved Bacteroidetes antigen induces anti-inflammatory intestinal T lymphocytes

Djenet Bousbaine,Laura I. Fisch,Mariya London,Preksha Bhagchandani,Tiago B. Rezende de Castro,Mark Mimee,Scott Olesen,Bernardo S. Reis,David VanInsberghe,Juliana Bortolatto,Mathilde Poyet,Ross W. Cheloha,John Sidney,Jingjing Ling,Aaron Gupta,Timothy K. Lu,Alessandro Sette,Eric J. Alm,James J. Moon,Gabriel D. Victora,Daniel Mucida,Hidde L. Ploegh,Angelina M. Bilate

DOI: https://doi.org/10.1126/science.abg5645

IF: 56.9

2022-08-05

Science

Abstract:The microbiome contributes to the development and maturation of the immune system. In response to commensal bacteria, intestinal CD4 + T lymphocytes differentiate into functional subtypes with regulatory or effector functions. The development of small intestine intraepithelial lymphocytes that coexpress CD4 and CD8αα homodimers (CD4IELs) depends on the microbiota. However, the identity of the microbial antigens recognized by CD4 + T cells that can differentiate into CD4IELs remains unknown. We identified β-hexosaminidase, a conserved enzyme across commensals of the Bacteroidetes phylum, as a driver of CD4IEL differentiation. In a mouse model of colitis, β-hexosaminidase–specific lymphocytes protected against intestinal inflammation. Thus, T cells of a single specificity can recognize a variety of abundant commensals and elicit a regulatory immune response at the intestinal mucosa.

multidisciplinary sciences
Gastro-intestinal tract: The leading role of mucosal immunity

Anna Steinert,Katarina Radulovic,Jan Niess

DOI: https://doi.org/10.4414/smw.2016.14293

2016-04-05

Abstract:An understanding of mucosal immunity is essential for the comprehension of intestinal diseases that are often caused by a complex interplay between host factors, environmental influences and the intestinal microbiota. Not only improvements in endoscopic techniques, but also advances in high throughput sequencing technologies, have expanded knowledge of how intestinal diseases develop. This review discusses how the host interacts with intestinal microbiota by the direct contact of host receptors with highly conserved structural motifs or molecules of microbes and also by microbe-derived metabolites (produced by the microbe during adaptation to the gut environment), such as short-chain fatty acids, vitamins, bile acids and amino acids. These metabolites are recognised by metabolite-sensing receptors expressed by immune cells to influence functions of macrophages, dendritic cells and T cells, such as migration, conversion and maintenance of regulatory T cells and regulation of proinflammatory cytokine production, which is essential for the maintenance of intestinal homeostasis and the development of intestinal diseases, such as inflammatory bowel diseases. First interventions in these complex interactions between microbe-derived metabolites and the host immune system for the treatment of gastrointestinal diseases, such as modification of the diet, treatment with antibiotics, application of probiotics and faecal microbiota transplantation, have been introduced into the clinic. Specific targeting of metabolite sensing receptors for the treatment of gastrointestinal diseases is in development. In future, precision medicine approaches that consider individual variability in genes, the microbiota, the environment and lifestyle will become increasingly important for the care of patients with gastrointestinal diseases.
Analysis of variance for repeated measures. Data: a generalized estimating equations approach.

G. J. Carr,E. M. Chi

DOI: https://doi.org/10.1002/SIM.4780110805

Statistics in Medicine

Abstract:Various techniques are available for the analysis of repeated measures data, and the appropriate choice depends on distributional assumptions and study design features. A correct analysis must account for potential dependence between repeated observations on the same subject. Liang and Zeger proposed a more unified approach to the analysis of repeated measures data based on the application of generalized estimating equations. We examine the application of these methods to several types of data in which one estimates the mean response directly for each combination of discrete covariates, and uses an identity link. Computations for fitting this type of model are exceptionally simple. Numerical examples suggest that the proposed approach yields estimation and hypothesis testing results consistent with more specialized methods.

Bronchial adenoma: an unusual cause of recurrent pneumonia in childhood.

Immune Responses to Broad-Spectrum Antibiotic Treatment and Fecal Microbiota Transplantation in Mice

Enterocloster clostridioformis induces host intestinal epithelial responses that protect against Salmonella infection

Citrobacter rodentium–host–microbiota interactions: immunity, bioenergetics and metabolism

Genome-guided design of a defined mouse microbiota that confers colonization resistance against Salmonella enterica serovar Typhimurium

Intestinal Microbiota as a Host Defense Mechanism to Infectious Threats

Klebsiella Michiganensis Transmission Enhances Resistance to Enterobacteriaceae Gut Invasion by Nutrition Competition

Commensal microbiome and gastrointestinal mucosal immunity: Harmony and conflict with our closest neighbor

Host innate and adaptive immunity shapes the gut microbiota biogeography

Host-recognition of pathogens and commensals in the mammalian intestine

Selective influence of host microbiota on cAMP-mediated ion transport in mouse colon

Select mucosa-associated intestinal commensal bacteria promote gut barrier repair by inducing IL-1b production

Modulation of Mucosal Immune Response, Tolerance, and Proliferation in Mice Colonized by the Mucin-Degrader Akkermansia muciniphila

Microbiota-mediated colonization resistance against intestinal pathogens

Gut complement induced by the microbiota combats pathogens and spares commensals

Sequestration of gut pathobionts in intraluminal casts, a mechanism to avoid dysregulated T cell activation by pathobionts

[Experimental study of influenza-diphtheria-whooping cough vaccine. (Part I) Immunological reaction to influenza antigen].

Human gut commensal modulates the host lipidome and delivers anti-inflammatory outer membrane vesicles to suppress colitis in an -deficient mouse model

A conserved Bacteroidetes antigen induces anti-inflammatory intestinal T lymphocytes

Gastro-intestinal tract: The leading role of mucosal immunity

Analysis of variance for repeated measures. Data: a generalized estimating equations approach.